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Abstract
Recently, many studies have reported that the SNP+45(T.G) and SNP+276(G.T) polymorphisms in the adiponectin gene
are associated with type 2 diabetes (T2DM) in the Chinese Han population. However, the previous studies yielded many
conflicting results. Thus, a meta-analysis of the association of the adiponectin gene with T2DM in the Chinese Han
population is required. In the current study, we first determined the distribution of the adiponectin SNP+276 polymorphism
in T2DM and nondiabetes (NDM) control groups. Our results suggested that the genotype and allele frequencies for
SNP+276 did not differ significantly between the T2DM and NDM groups. Then, a meta-analysis of 23 case-control studies of
SNP+45, with a total of 4161 T2DM patients and 3709 controls, and 11 case-control studies of SNP+276, with 2533 T2DM
patients and 2212 controls, was performed. All subjects were Han Chinese. The fixed-effects model and random-effects
model were applied for dichotomous outcomes to combine the results of the included studies. The results revealed a trend
towards an increased risk of T2DM for the SNP+45G allele as compared with the SNP+45T allele (OR=1.34; 95% CI, 1.11–
1.62; P,0.01) in the Chinese Han population. However, there was no association between SNP+276 and T2DM (OR=0.90;
95% CI, 0.73–1.10; P=0.31). The results of our association study showed there was no association between the adiponectin
SNP+276 polymorphism and T2DM in the Yunnan Han population. The meta-analysis results suggested that the SNP+45G
allele might be a susceptibility allele for T2DM in the Chinese Han population. However, we did not observe an association
between SNP+276 and T2DM.
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Introduction
Diabetes mellitus comprises a group of metabolic disorders that
are characterized by chronic hyperglycemia. Type 2 diabetes
(T2DM) and its complications impose a tremendous burden both
on individuals with diabetes and on the health care system.
Adiponectin is an important adipocytokine that is secreted by
adipocytes and plays a key role in the regulation of insulin sensitivity
and glucose homeostasis[1,2,3,4]. Serum adiponectin concentra-
tions are decreased in patients with T2DM, obesity, and meta-
bolic syndrome[4,5,6,7]. Many studies have reported that single
nucleotide polymorphisms (SNPs) in the adiponectin gene are
associated with T2DM indifferent populations[8,9,10,11,12,13,14].
However, the results of these studies are confusing rather than
conclusive, and show strong racial and regional variations
[11,13,15,16,17,18,19,20].
The Chinese population comprises 56 ethnic groups, of which
Han is the largest (approximately 93% of the total population). The
Han are descended from the Huaxia tribe who lived in the area of
the Yellow River, and then migrated to the area of the Yangtze
River. The Han have now spread throughout the country and live
in different regions of China. Many studies that investigated the
association in the Chinese Han population between T2DM and
SNPs in the adiponectin gene have been reported recently
[16,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,
39,40,41,42,43]. Two SNPs in particular have been analyzed:
rs2241766 (+45 T.G in exon 2) and rs1501299 (+276 G.Ti n
intron2).A seriesofassociationstudieswascarriedouttoinvestigate
the relationship between these two SNPs and T2DM in the Han
population in different regions of China. However, the results were
still fairly contradictory, and showed regional variation. Therefore,
a meta-analysis of the association of the adiponectin gene
polymorphisms SNP+45 and SNP+276 with T2DM in the Chinese
HanpopulationisnecessaryinordertoclarifytheroleoftheseSNPs
in T2DM.
The aim of the current study was first to evaluate the association
of SNP+276 with T2DM in the Han population in Yunnan
Province, in the southwest of China. Then, we combined our data
with those of 25 previous studies for a carefully designed meta-
analysis to investigate the association of the SNP+45 and
SNP+276 polymorphisms in the adiponectin gene with T2DM
in the Chinese Han population. Our study will provide a more
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19686thorough evaluation of the significance of the association of the
SNP+45 and SNP+276 polymorphisms with T2DM in the
Chinese Han population.
Results
1. Association study results
1.1 Clinical characteristics of the enrolled subjects. The
clinical characteristics of the enrolled subjects are presented in
Table S1. Anthropometric parameters (BMI, WC, and HC) were
significantly higher in patients with T2DM than in NDM subjects.
Although fasting insulin did not differ between the T2DM and
NDM groups, the T2DM subjects had a significantly higher
insulin resistance index.
1.2 Association of SNP+276 and T2DM. SNP+276
conformed to HWE in both the T2DM group and the NDM
group (P=0.72 and P=0.34), respectively. The allele and
genotype frequencies for SNP+276 are shown in Table S2.
T h ea l l e l ef r e q u e n c i e sf o rS N P +276 were 0.71 for G and 0.29 for
T in the T2DM group. In the NDM group, the allele frequencies
were 0.68 for G and 0.32 for T. The genotype frequencies for
SNP+276 were 0.51 for GG, 0.40 for GT, and 0.09 for TT in the
T2DM group. In the NDM group, the genotype frequencies
were 0.45 for GG, 0.47 for GT, and 0.08 for TT. The genotype
frequencies for SNP+276 showed no significant differences
between the T2DM and NDM groups (x
2=1.59, P=0.45).
After adjusting age and gender, the genotype frequencies for
SNP+276 also showed no significant differences between the
T2DM and NDM groups (x
2=3.74, P=0.15). In addition, the
allele frequencies for SNP+276 showed no significant dif-
ferences between the T2DM and NDM groups (x
2=0.65,
P=0.42, OR =0.87).
2. Meta-analysis result
2.1 Flow of included studies. The initial search strategy to
identify association studies for T2DM and SNPs in the adiponectin
gene yielded a total of 262 potentially relevant references among
all the databases, 146 of which were overlapping. After subsequent
screening, 26 studies were identified for recruitment in the light of
the inclusion criteria.
2.2 Study characteristics. Table S3 and S4 show the 23
case-control studies for SNP+45, with a total of 4161 T2DM
subjects and 3709 NDM subjects, and 11 case-control studies for
SNP+276, with a total of 2533 T2DM subjects and 2212 NDM
subjects, that were included in the analysis, respectively
[16,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,
39,40,41,42,43]. All subjects were selected randomly without sex
or age restriction. The diagnosis of T2DM followed the 1999
WHO Diabetes Criteria, except for one study that used the 1985
WHO criteria[23].
2.3 Association of SNP+45 and SNP+276 with
T2DM. Fig. 1 and Fig. 2 show the ORs and 95% CI for the
association of T2DM with SNP+45 and SNP+276, respectively, in
individual studies. There was significant heterogeneity among the
results of the individual studies, Pheterogeneity ,0.01, I
2=84.6%
for SNP+45 and Pheterogeneity ,0.01, I
2=76.9% for SNP+276.
Therefore, the random-effects model (I-V heterogeneity) was used
to calculate the pooled ORs and 95% CI for both SNPs. Overall,
there was a trend towards an increased risk of T2DM for the
SNP+45G allele as compared with the SNP+45T allele
(OR=1.34, 95% CI=1.11–1.62, P,0.01). However, there was
no trend towards an increased risk of T2DM for the SNP+276T
allele as compared with the SNP+276G allele (OR=0.90, 95%
CI=0.73–1.10, P=0.31).
2.4 Publication bias. Begg’s funnel plot and Egger’s test
were performed to determine whether the literature showed a
publication bias. The Begg’s funnel plots were symmetrical by
visual inspection (Fig. 3 and Fig. 4), and neither the Begg’s test nor
the Egger’s test suggested publication bias. The P-values for
Egger’s test were 0.07 (95% CI=22.97 to 5.85) for SNP+45 and
0.60 (95% CI=24.69 to 2.87) for SNP+276.
2.5 Sensitivity analysis. A sensitivity analysis was performed
by omitting one study at a time and calculating the pooled ORs for
the remaining studies. This analysis showed that none of the
individual studies influenced the pooled ORs, which ranged from
1.29 (95% CI=1.08–1.55) to 1.41 (95% CI=1.19–1.69) for
SNP+45, and 0.85 (95% CI=0.76–0.96) to 0.97 (95% CI=0.88–
1.06) for SNP+276. The sensitivity analysis indicated that the
results of the meta-analysis were reliable and stable.
Discussion
The adiponectin gene is located on human chromosome 3q27,
where a region identified as a susceptibility locus for metabolic
syndrome and T2DM has been reported, and is composed of three
exons that span 17 kb[44,45,46,47]. Two common SNPs in the
adiponectin gene (SNP+45 and SNP+276) were determined to be
associated with T2DM in the Japanese population by Hara
et al[11]. They observed that Japanese subjects with the
SNP+45GG genotype or SNP+276GG genotype had a significantly
increased risk of T2DM. In the current study, the associations of the
SNP+276 alleles and genotypes with T2DM were assessed
separately, and no significant association of SNP+276 with
T2DM was found. These results were similar to some previous
studies of the Chinese Han population[19,20,23,26,37], but
contradicted other studies that showed there was a significant
association of SNP+276 with T2DM [32,35]. The conflicting results
indicated that a meta-analysis should be performed to determine
whether these SNPs in the adiponectin gene were associated with
T2DM in the Chinese Han population.
To the best of our knowledge, this is one of the largest
systematic reviews of the literature that has used a meta-analysis to
study the association between the SNP+45 and SNP+276
polymorphisms and T2DM in Chinese Han populations. The
previous meta-analysis included eight papers for SNP+45 and four
papers for SNP+276[48], whereas we combined our results with
those of recently published studies, namely 23 papers for SNP+45
and 11 papers for SNP+276. As a result, we were able to conduct a
comprehensive meta-analysis in which the number of studies was
almost three times higher than in the previous analysis[48].
HWE is the principal law in population genetic studies. If a
locus conforms with HWE, the samples are representative. In
fifteen studies of SNP+45 and nine studies of SNP+276, the
genotypes in both the T2DM and NDM groups conformed with
HWE. Therefore, a further meta-analysis was performed in which
only the studies that conformed with HWE were included. The
further meta-analysis data showed that there was heterogeneity
among the results of the individual studies, Pheterogeneity ,0.01,
I
2=76.9% for SNP+45 and Pheterogeneity ,0.01, I
2=71.3% for
SNP+276. The results from the application of the random-effect
models revealed that subjects who carried the SNP+45G allele had
a significantly increased risk of T2DM as compared with those
who carried the SNP+45T allele (OR=1.40; 95% CI, 1.16–1.68;
P,0.01). However, there was no trend towards an increased risk
of T2DM for the SNP+276T allele as compared with the
SNP+276G allele (OR=0.93; 95% CI, 0.76–1.14; P=0.46).
These results were similar to those of the initial meta-analysis in
which all the studies were included.
Adiponectin Gene and T2DM Risk
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results of meta-analysis [49]. Our meta-analysis revealed signifi-
cant between-study heterogeneity for SNP+45 (Pheterogeneity ,0.01,
I
2=84.6%) and SNP+276 (SNP+276 Pheterogeneity ,0.01,
I
2=76.9%). All of the subjects in the current meta-analysis study
were Han Chinese but from different regions and the Han Chinese
population is not a genetically homogenous group. Thus, this
might explain the significant between-study heterogeneity. The
differences in age and gender distributions among the included
studies, and differences in sample content might also contribute to
the heterogeneity.
In 2002, Hara et al first reported that the SNP45+GG genotype
of the adiponectin gene was associated with T2DM in the
Japanese population[11]. In 2005, Zacharova et al investigated
the SNP+45 and SNP+276 polymorphisms of the adiponectin
gene as predictors of the conversion from impaired glucose
tolerance to T2DM in the STOP-NIDDM trial[50]. They
observed that the SNP+45G allele was associated with a 1.8-
fold increased risk of T2DM (95% CI, 1.12–3.00; P=0.015) in
the placebo group[50]. As a consequence, they concluded that
the SNP+45G allele is a predictor of conversion to T2DM [50].
Many studies on the Chinese population also observed an
association between the SNP+45G allele and T2DM
[20,21,33,38,39]. These results agreed with our meta-analysis
data (OR=1.34; 95% CI, 1.11–1.62; P,0.01). Thus, we inferred
that the SNP+45G allele might be a susceptibility allele for
T2DM. However, the SNP+45 polymorphism, which is located
within exon 2 of the adiponectin gene, does not alter the amino
acid sequence of the adiponectin protein. Thus, rather than
having a direct effect itself, SNP+45 might be in linkage
disequilibrium with a polymorphism in one of the introns that
destabilizes the pre-mRNA, results in reduced mRNA levels, and
finally leads to pathophysiological effects[51]. Systematic screen-
ing of the intronic regions of the adiponectin gene to identify
other SNPs should clarify why the SNP+45G allele is associated
with T2DM in many studies and in our meta-analysis.
Figure 1. Individual and pooled ORs and 95% CI for SNP+45 (G vs.T) for all studies.
doi:10.1371/journal.pone.0019686.g001
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doi:10.1371/journal.pone.0019686.g002
Figure 3. Begg’s funnel plot analysis for the comparison of the SNP+45 alleles. P value of Begg’s test was 0.79 (continuity corrected).
doi:10.1371/journal.pone.0019686.g003
Adiponectin Gene and T2DM Risk
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adiponectin gene was associated with T2DM in the Japanese
population[11]. However, we did not observe any association of
SNP276 with T2DM in the current study. Many other studies also
did not observe this association in the Chinese Han popula-
tion[19,20,23,26,37]. In addition, the results of our meta-analysis
showed no significant association between SNP+276 and T2DM
(OR=0.90; 95% CI, 0.73–1.10; P=0.31). Possible explanations for
the absence of an association with T2DM are: (a) the SNP+276
polymorphism in the adiponectin gene is not a candidate SNP for
T2DM in the Chinese Han population; (b) the effect of SNP+276
might be masked by the summed effects of other unidentified
genetic factors; (c) only 11 studies were included in our meta-
analysis. Thus, a conclusive assessment of the possible association
probably requires the inclusion of more studies and larger sample
sizes. It was an interesting finding that the SNP+45 and SNP+276
are only 231 bp far away in adiponectin gene, however, only
SNP+45 associated with T2DM in our meta-analysis. Wang et al.
reported that SNP+45 just were partly in linkage disequilibrium
with SNP+276 in Chinese Han[37]. Therefore, we assumed this
could be possible one of causes of the divergence that only SNP+45
associated with T2DM in Han Chinese, but not SNP+276.
The results of our meta-analysis demonstrated that the
SNP+45G allele might be a susceptibility allele for T2DM.
However, we could not observe any association of SNP+276 with
T2DM. As we know, T2DM is influenced by gene–environment
interactions. In addition, many genetic factors, including the
adiponectin gene, influence the occurrence of T2DM. Therefore,
in order to understand the mechanisms underlying T2DM better,
future research should be considered and carried out to explore
the effects of gene–gene interactions, environmental factors, and
individual genetic background.
Materials and Methods
1. Association study between SNP+276 and T2DM
1.1 Ethics statement. All participants gave written informed
consent. The protocol was in accordance with the Helsinki
Declaration, and was approved by the Institutional Review Boards
of the Second People’s Hospital of Yunnan Province.
1.2 Subjects. The study included 202 patients (males=121;
females=81) who were diagnosed with T2DM at the Second
People’s Hospital of Yunnan Province from December 2006 to
September 2010. T2DM was confirmed using the criteria of the
World Health Organization from 1999. Patients who were treated
with insulin or an insulin secretagogue were excluded from the
study. The nondiabetes group (NDM) included 143 subjects
(males=59; females=84) who had no family history of diabetes
mellitus and were recruited from an unselected population
undergoing routine health checkups at the Second People’s
Hospital of Yunnan Province. Subjects with diabetes or
impaired glucose tolerance were excluded from the NDM group
on the basis of an oral glucose tolerance test. In addition, subjects
with hypertension or coronary heart disease were also excluded
from the study. All participants were ethnic Han by self report.
1.3 Clinic measurements. Weight, height, waist circum-
ference (WC), and hip circumference (HC) were measured by
trained personnel in duplicate and the results were averaged. WC
was measured midway between the lower rib margin and the iliac
crest. HC was measured at the level of the greater trochanter.
Body mass index (BMI) was calculated as weight (kg) divided by
the square of height (m
2). Waist to hip ratio (WHR) was calculated
as WC divided by HC.
1.4 Laboratory measurements. Venous blood samples
were collected in the morning after the subjects had fasted for
12 hours. Fasting plasma glucose (FPG) was assayed by the glucose
oxidase method using a HITACHI 7600-020 Automatic Analyzer.
Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-
C), and triglycerides (TG) were determined by enzymatic methods
with a HITACHI 7600-020 Automatic Analyzer. Low-density
lipoprotein cholesterol (LDL-C) was calculated by using the
Friedewald formula. Glycosylated hemoglobin (HbA1c) was
determined by immunoturbidimetry with a HITACHI 7600-020
Automatic Analyzer. Fasting serum insulin was measured by
radioimmunoassay with a Gamma counter. Insulin resistance was
assessed by homeostatic model assessment (HOMA; insulin
resistance index = [fasting glucose (mmol/L)6fasting insulin
(mU/ml)]/22.5).
1.5 Genotyping the SNP+276 polymorphisms in the
adiponectin gene. Genomic DNA was extracted from
Figure 4. Begg’s funnel plot analysis for the comparison of the SNP+276 alleles. P value of Begg’s test was 0.76 (continuity corrected).
doi:10.1371/journal.pone.0019686.g004
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chloroform method. SNP+276 (rs1501299) was genotyped by the
polymerase chain reaction-based restriction fragment-length
polymorphism (PCR-RFLP) method. The PCR product was
745 bp and was digested with BmsI into fragments of 523 bp and
222 bp. The digested products were subjected to electrophoresis
through a 2% agarose gel, stained with ethidium bromide, and
visualized under ultraviolet light. Some of the PCR products were
characterized by direct sequencing (3100 Genetic Analyzer;
Applied Biosystems, Tokyo, Japan) using a BigDye Terminator
v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA,
USA) after purification with Sephadex
TM G-50 (GE Healthcare,
Piscataway, NJ, USA).
1.6 Statistical analysis for the population and case-control
study. The allele and genotype frequencies for SNP+276 were
calculated by the direct-counting method. Hardy–Weinberg
equilibrium (HWE) was tested in both the cases and the controls
(http://ihg2.helmholtz-muenchen.de/cgi-bin/hw/hwa1.pl). A x
2
test was used to determine differences in allele and genotype
frequencies between T2DM subjects and NDM subjects. The
association of SNPs with T2DM was assessed by logistic regression
after adjusting for age and gender. A P value of less than 0.05 was
considered statistically significant.
2. Meta-analysis Study
2.1 Search strategy. Our meta-analyses use the PRISMA
statement as a guide. All of the studies included in the meta-
analysis were studies of the association between the adiponectin
SNPs and T2DM in Chinese populations. Sources included the
MEDLINE, EMBASE, Chinese VIP, Chinese CNKI, and
Chinese WanFang databases (up to February 2011). The search
terms were as follows: ‘adiponectin’ OR ‘APM1’, ‘polymorphism’
AND ‘type 2 diabetes mellitus’, ‘China’ OR ‘Chinese’.
2.2 Selection. To be included in the meta-analysis, studies
had to meet all the following criteria: (a) an unrelated case-control
design, (b) all subjects were Han Chinese, (c) available genotype
and allele numbers or frequencies, (d) published in any language.
PCR-single stranded conformational polymorphism (PCR-SSCP)
or PCR-RFLP analysis and DNA sequencing were used to
examine the mutations in the adiponectin gene. If there were
multiple publications from the same group, only the most recent
study was included in the analysis.
2.3 Data extraction and study characteristics. The two
authors who conducted the literature search (Yiping Li and Li Shi)
also extracted the data from the studies independently. Any
disagreement was adjudicated by consensus and by consulting two
additional authors (Ying Zhang and Yufeng Yao). Author name,
journal and year of publication, region of origin, diagnosis criteria
for T2DM, size of case and control groups, and adiponectin SNP
loci analyzed were collected. Sample sizes, genotype and allele
numbers, and P values for HWE in the T2DM and NDM groups
were summarized (Table S3 and Table S4).
2.4 Statistical meta-analysis. Hardy–Weinberg equili-
brium (HWE) was tested for all studies included (http://ihg2.
helmholtz-muenchen.de/cgi-bin/hw/hwa1.pl). Then, we compared
T2DM cases with controls by using the allele model (A/a) for each
SNP. The odds ratios (ORs) and 95% confidence intervals (CI) were
calculated to determine the differences in each SNP between the
T2DM and NDM groups. The x
2-based Q statistic test was used to
assess the between-study heterogeneity[52]. Heterogeneity was
considered significant at a P value of ,0.10. The inconsistency
index I
2 was also calculated to evaluate the amount of variation that
was caused by heterogeneity rather than by chance: higher values of
the index indicate the existence of heterogeneity[53]. Data were
combined using both fixed-effects (Mantel–Haenszel) and random-
effects (I-V heterogeneity) models. The fixed-effects model (if
p.0.10) or the random-effects model (if p,0.10) was used to pool
the results. From the individual ORs, a pooled OR was estimated,
whose statistical significance was determined using the Z-test.
Sensitivity analysis was performed to assess the stability of these
results.Potential publication bias wasestimated byBegg’s funnel plot
and Egger’s linear regression test. P,0.05 was considered to
represent a statistically significant publication bias[54,55]. All P-
values were two-sided. All meta-analysis was performed using Stata
statistical software (STATA version SE-10.1; Stata Corporation,
College Station, TX).
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